% alzhub.org library filter % Source: https://alzhub.org/research?author=Hansson+O&atag=csf % 32 entries, in the order the page lists them. Built from alzhub.org's own records. % 0 entries have no readable author in the source record and carry no author field. @article{mattsson2009-19622817, author = {Mattsson, N. and Zetterberg, H. and Hansson, O. and Andreasen, N. and Parnetti, L. and Jonsson, M. and Herukka, S. K. and van der Flier, W. M. and others}, title = {{CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment}}, journal = {JAMA}, year = {2009}, doi = {10.1001/jama.2009.1064}, pmid = {19622817}, url = {https://doi.org/10.1001/jama.2009.1064} } @article{janelidze2018-30054439, author = {Janelidze, S. and Mattsson, N. and Stomrud, E. and Lindberg, O. and Palmqvist, S. and Zetterberg, H. and Blennow, K. and Hansson, O.}, title = {{CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease}}, journal = {Neurology}, year = {2018}, doi = {10.1212/wnl.0000000000006082}, pmid = {30054439}, url = {https://doi.org/10.1212/wnl.0000000000006082} } @article{palmqvist2016-26936941, author = {Palmqvist, S. and Mattsson, N. and Hansson, O. and {Alzheimer’s Disease Neuroimaging Initiative}}, title = {{Cerebrospinal fluid analysis detects cerebral amyloid-β accumulation earlier than positron emission tomography}}, journal = {Brain : a journal of neurology}, year = {2016}, doi = {10.1093/brain/aww015}, pmid = {26936941}, url = {https://doi.org/10.1093/brain/aww015} } @article{janelidze2023-36987840, author = {Janelidze, S. and Barthélemy, N. R. and He, Y. and Bateman, R. J. and Hansson, O.}, title = {{Mitigating the Associations of Kidney Dysfunction With Blood Biomarkers of Alzheimer Disease by Using Phosphorylated Tau to Total Tau Ratios}}, journal = {JAMA neurology}, year = {2023}, doi = {10.1001/jamaneurol.2023.0199}, pmid = {36987840}, url = {https://doi.org/10.1001/jamaneurol.2023.0199} } @article{cicognola2021-33773595, author = {Cicognola, C. and Janelidze, S. and Hertze, J. and Zetterberg, H. and Blennow, K. and Mattsson-Carlgren, N. and Hansson, O.}, title = {{Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment}}, journal = {Alzheimer's research \& therapy}, year = {2021}, doi = {10.1186/s13195-021-00804-9}, pmid = {33773595}, url = {https://doi.org/10.1186/s13195-021-00804-9} } @article{hansson2023-37202517, author = {Hansson, O. and Blennow, K. and Zetterberg, H. and Dage, J.}, title = {{Blood biomarkers for Alzheimer's disease in clinical practice and trials}}, journal = {Nature aging}, year = {2023}, doi = {10.1038/s43587-023-00403-3}, pmid = {37202517}, url = {https://doi.org/10.1038/s43587-023-00403-3} } @article{hansson2018-29499171, author = {Hansson, O. and Seibyl, J. and Stomrud, E. and Zetterberg, H. and Trojanowski, J. Q. and Bittner, T. and Lifke, V. and Corradini, V. and others}, title = {{CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts}}, journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association}, year = {2018}, doi = {10.1016/j.jalz.2018.01.010}, pmid = {29499171}, url = {https://doi.org/10.1016/j.jalz.2018.01.010} } @article{gertje2023-36882326, author = {Gertje, E. C. and Janelidze, S. and van Westen, D. and Cullen, N. and Stomrud, E. and Palmqvist, S. and Hansson, O. and Mattsson-Carlgren, N.}, title = {{Associations Between CSF Markers of Inflammation, White Matter Lesions, and Cognitive Decline in Individuals Without Dementia}}, journal = {Neurology}, year = {2023}, doi = {10.1212/wnl.0000000000207113}, pmid = {36882326}, url = {https://doi.org/10.1212/wnl.0000000000207113} } @article{ossenkoppele2019-30626656, author = {Ossenkoppele, R. and Smith, R. and Ohlsson, T. and Strandberg, O. and Mattsson, N. and Insel, P. S. and Palmqvist, S. and Hansson, O.}, title = {{Associations between tau, Aβ, and cortical thickness with cognition in Alzheimer disease}}, journal = {Neurology}, year = {2019}, doi = {10.1212/wnl.0000000000006875}, pmid = {30626656}, url = {https://doi.org/10.1212/wnl.0000000000006875} } @article{duits2014-24721526, author = {Duits, F. H. and Teunissen, C. E. and Bouwman, F. H. and Visser, P. J. and Mattsson, N. and Zetterberg, H. and Blennow, K. and Hansson, O. and others}, title = {{The cerebrospinal fluid "Alzheimer profile": easily said, but what does it mean?}}, journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association}, year = {2014}, doi = {10.1016/j.jalz.2013.12.023}, pmid = {24721526}, url = {https://doi.org/10.1016/j.jalz.2013.12.023} } @article{cicognola2021-d7e9adeb, author = {Cicognola, C. and Janelidze, S. and Hertze, J. and Zetterberg, H. and Blennow, K. and Mattsson-Carlgren, N. and Hansson, O.}, title = {{Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment}}, journal = {Alzheimer's Research \& Therapy}, year = {2021}, pmid = {33773595} } @article{mattsson2012-22302554, author = {Mattsson, N. and Rosén, E. and Hansson, O. and Andreasen, N. and Parnetti, L. and Jonsson, M. and Herukka, S. K. and van der Flier, W. M. and others}, title = {{Age and diagnostic performance of Alzheimer disease CSF biomarkers}}, journal = {Neurology}, year = {2012}, doi = {10.1212/wnl.0b013e3182477eed}, pmid = {22302554}, url = {https://doi.org/10.1212/wnl.0b013e3182477eed} } @article{hansson2006-16488378, author = {Hansson, O. and Zetterberg, H. and Buchhave, P. and Londos, E. and Blennow, K. and Minthon, L.}, title = {{Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study}}, journal = {The Lancet. Neurology}, year = {2006}, doi = {10.1016/s1474-4422(06)70355-6}, pmid = {16488378}, url = {https://doi.org/10.1016/s1474-4422(06)70355-6} } @article{janelidze2016-26783546, author = {Janelidze, S. and Hertze, J. and Zetterberg, H. and Landqvist Waldö, M. and Santillo, A. and Blennow, K. and Hansson, O.}, title = {{Cerebrospinal fluid neurogranin and YKL-40 as biomarkers of Alzheimer's disease}}, journal = {Annals of clinical and translational neurology}, year = {2016}, doi = {10.1002/acn3.266}, pmid = {26783546}, url = {https://doi.org/10.1002/acn3.266} } @article{hansson2019-31010420, author = {Hansson, O. and Lehmann, S. and Otto, M. and Zetterberg, H. and Lewczuk, P.}, title = {{Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer's Disease}}, journal = {Alzheimer's research \& therapy}, year = {2019}, doi = {10.1186/s13195-019-0485-0}, pmid = {31010420}, url = {https://doi.org/10.1186/s13195-019-0485-0} } @article{rosen2013-23800368, author = {Rosén, C. and Hansson, O. and Blennow, K. and Zetterberg, H.}, title = {{Fluid biomarkers in Alzheimer's disease - current concepts}}, journal = {Molecular neurodegeneration}, year = {2013}, doi = {10.1186/1750-1326-8-20}, pmid = {23800368}, url = {https://doi.org/10.1186/1750-1326-8-20} } @article{buchhave2012-22213792, author = {Buchhave, P. and Minthon, L. and Zetterberg, H. and Wallin, A. K. and Blennow, K. and Hansson, O.}, title = {{Cerebrospinal fluid levels of β-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia}}, journal = {Archives of general psychiatry}, year = {2012}, doi = {10.1001/archgenpsychiatry.2011.155}, pmid = {22213792}, url = {https://doi.org/10.1001/archgenpsychiatry.2011.155} } @article{wallin2010-20458070, author = {Wallin, A. K. and Blennow, K. and Zetterberg, H. and Londos, E. and Minthon, L. and Hansson, O.}, title = {{CSF biomarkers predict a more malignant outcome in Alzheimer disease}}, journal = {Neurology}, year = {2010}, doi = {10.1212/wnl.0b013e3181dd4dd8}, pmid = {20458070}, url = {https://doi.org/10.1212/wnl.0b013e3181dd4dd8} } @article{cullen2022-34937781, author = {Cullen, N. and Janelidze, S. and Palmqvist, S. and Stomrud, E. and Mattsson-Carlgren, N. and Hansson, O. and {Alzheimer’s Disease Neuroimaging Initiative}}, title = {{Association of CSF Aβ38 Levels With Risk of Alzheimer Disease-Related Decline}}, journal = {Neurology}, year = {2022}, doi = {10.1212/wnl.0000000000013228}, pmid = {34937781}, url = {https://doi.org/10.1212/wnl.0000000000013228} } @article{stomrud2010-20142530, author = {Stomrud, E. and Hansson, O. and Zetterberg, H. and Blennow, K. and Minthon, L. and Londos, E.}, title = {{Correlation of longitudinal cerebrospinal fluid biomarkers with cognitive decline in healthy older adults}}, journal = {Archives of neurology}, year = {2010}, doi = {10.1001/archneurol.2009.316}, pmid = {20142530}, url = {https://doi.org/10.1001/archneurol.2009.316} } @article{lindqvist2013-23911592, author = {Lindqvist, D. and Hall, S. and Surova, Y. and Nielsen, H. M. and Janelidze, S. and Brundin, L. and Hansson, O.}, title = {{Cerebrospinal fluid inflammatory markers in Parkinson's disease--associations with depression, fatigue, and cognitive impairment}}, journal = {Brain, behavior, and immunity}, year = {2013}, doi = {10.1016/j.bbi.2013.07.007}, pmid = {23911592}, url = {https://doi.org/10.1016/j.bbi.2013.07.007} } @article{demeyer2010-20697045, author = {De Meyer, G. and Shapiro, F. and Vanderstichele, H. and Vanmechelen, E. and Engelborghs, S. and De Deyn, P. P. and Coart, E. and Hansson, O. and others}, title = {{Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people}}, journal = {Archives of neurology}, year = {2010}, doi = {10.1001/archneurol.2010.179}, pmid = {20697045}, url = {https://doi.org/10.1001/archneurol.2010.179} } @article{hall2018-30185816, author = {Hall, S. and Janelidze, S. and Surova, Y. and Widner, H. and Zetterberg, H. and Hansson, O.}, title = {{Cerebrospinal fluid concentrations of inflammatory markers in Parkinson's disease and atypical parkinsonian disorders}}, journal = {Scientific reports}, year = {2018}, doi = {10.1038/s41598-018-31517-z}, pmid = {30185816}, url = {https://doi.org/10.1038/s41598-018-31517-z} } @article{wennstrom2015-26270969, author = {Wennström, M. and Surova, Y. and Hall, S. and Nilsson, C. and Minthon, L. and Hansson, O. and Nielsen, H. M.}, title = {{The Inflammatory Marker YKL-40 Is Elevated in Cerebrospinal Fluid from Patients with Alzheimer's but Not Parkinson's Disease or Dementia with Lewy Bodies}}, journal = {PloS one}, year = {2015}, doi = {10.1371/journal.pone.0135458}, pmid = {26270969}, url = {https://doi.org/10.1371/journal.pone.0135458} } @article{kumar2022-35641311, author = {Kumar, A. and Janelidze, S. and Stomrud, E. and Palmqvist, S. and Hansson, O. and Mattsson-Carlgren, N. and {Alzheimer's Disease Neuroimaging Initiative}}, title = {{β-Amyloid-Dependent and -Independent Genetic Pathways Regulating CSF Tau Biomarkers in Alzheimer Disease}}, journal = {Neurology}, year = {2022}, doi = {10.1212/wnl.0000000000200605}, pmid = {35641311}, url = {https://doi.org/10.1212/wnl.0000000000200605} } @article{andersson2023-36964585, author = {Andersson, E. and Schultz, N. and Saito, T. and Saido, T. C. and Blennow, K. and Gouras, G. K. and Zetterberg, H. and Hansson, O.}, title = {{Cerebral Aβ deposition precedes reduced cerebrospinal fluid and serum Aβ42/Aβ40 ratios in the AppNL-F/NL-F knock-in mouse model of Alzheimer's disease}}, journal = {Alzheimer's research \& therapy}, year = {2023}, doi = {10.1186/s13195-023-01196-8}, pmid = {36964585}, url = {https://doi.org/10.1186/s13195-023-01196-8} } @article{minta2019-31156172, author = {Minta, K. and Portelius, E. and Janelidze, S. and Hansson, O. and Zetterberg, H. and Blennow, K. and Andreasson, U.}, title = {{Cerebrospinal Fluid Concentrations of Extracellular Matrix Proteins in Alzheimer's Disease}}, journal = {Journal of Alzheimer's disease : JAD}, year = {2019}, doi = {10.3233/jad-190187}, pmid = {31156172}, url = {https://doi.org/10.3233/jad-190187} } @article{janelidze2019-31324260, author = {Janelidze, S. and Stomrud, E. and Brix, B. and Hansson, O.}, title = {{Towards a unified protocol for handling of CSF before β-amyloid measurements}}, journal = {Alzheimer's research \& therapy}, year = {2019}, doi = {10.1186/s13195-019-0517-9}, pmid = {31324260}, url = {https://doi.org/10.1186/s13195-019-0517-9} } @article{brinkmalm2014-25418885, author = {Brinkmalm, A. and Brinkmalm, G. and Honer, W. G. and Frölich, L. and Hausner, L. and Minthon, L. and Hansson, O. and Wallin, A. and others}, title = {{SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer's disease}}, journal = {Molecular neurodegeneration}, year = {2014}, doi = {10.1186/1750-1326-9-53}, pmid = {25418885}, url = {https://doi.org/10.1186/1750-1326-9-53} } @article{pereira2017-28692877, author = {Pereira, J. B. and Westman, E. and Hansson, O. and {Alzheimer's Disease Neuroimaging Initiative}}, title = {{Association between cerebrospinal fluid and plasma neurodegeneration biomarkers with brain atrophy in Alzheimer's disease}}, journal = {Neurobiology of aging}, year = {2017}, doi = {10.1016/j.neurobiolaging.2017.06.002}, pmid = {28692877}, url = {https://doi.org/10.1016/j.neurobiolaging.2017.06.002} } @article{brunnstrom2013-22911491, author = {Brunnström, H. and Hansson, O. and Zetterberg, H. and Londos, E. and Englund, E.}, title = {{Correlations of CSF tau and amyloid levels with Alzheimer pathology in neuropathologically verified dementia with Lewy bodies}}, journal = {International journal of geriatric psychiatry}, year = {2013}, doi = {10.1002/gps.3881}, pmid = {22911491}, url = {https://doi.org/10.1002/gps.3881} } @article{blennow2024-38818759, author = {Blennow, K. and Hansson, O.}, title = {{[Blood biomarkers open a window to brain pathophysiology in Alzheimer's disease]}}, journal = {Lakartidningen}, year = {2024}, pmid = {38818759} }